Much remains to be learned about the role of non-canonical and canonical NFκB pathway inhibition by IKK1 and IKK2 in lymphocytes in renal diseases, and time dependence after disease induction and differential activation of lymphocytes subsets in immune-mediated and non-immune-mediated disease models has to be evaluated further. Here, NFKB1 is linked to kidney disorder.